{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:01:36Z","timestamp":1794373296480,"version":"4.9.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41401-025-01651-2","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:35:19Z","timestamp":1757579719000},"page":"357-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Kr\u00fcppel-like factor 15 ameliorates alcohol-induced liver injury in mice via regulation of the PFKFB3\/AKT axis"],"prefix":"10.1038","volume":"47","author":[{"given":"Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-yuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-cheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-yao","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"1651_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"HK Seitz","year":"2018","unstructured":"Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, et al. Alcoholic liver disease. Nat Rev Dis Prim. 2018;4:16.","journal-title":"Nat Rev Dis Prim"},{"key":"1651_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","volume":"16","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16:235\u201346.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1651_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nrgastro.2017.116","volume":"15","author":"R Parker","year":"2018","unstructured":"Parker R, Kim SJ, Gao B. Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. Nat Rev Gastroenterol Hepatol. 2018;15:50\u20139.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1651_CR4","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke F. Targeting hepatic macrophages to treat liver diseases. J Hepatol. 2017;66:1300\u201312.","journal-title":"J Hepatol"},{"key":"1651_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41423-020-00560-0","volume":"18","author":"K Liu","year":"2021","unstructured":"Liu K, Wang FS, Xu R. Neutrophils in liver diseases: pathogenesis and therapeutic targets. Cell Mol Immunol. 2021;18:38\u201344.","journal-title":"Cell Mol Immunol"},{"key":"1651_CR6","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1002\/hep.31042","volume":"71","author":"S Rogal","year":"2020","unstructured":"Rogal S, Youk A, Zhang H, Gellad WF, Fine MJ, Good CB, et al. Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis. Hepatology. 2020;71:2080\u201392.","journal-title":"Hepatology"},{"key":"1651_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1115226","volume":"14","author":"H Chen","year":"2023","unstructured":"Chen H, Li LL, Du Y. Kruppel-like factor 15 in liver diseases: insights into metabolic reprogramming. Front Pharmacol. 2023;14:1115226.","journal-title":"Front Pharmacol"},{"key":"1651_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97937-6","volume":"11","author":"K Anzai","year":"2021","unstructured":"Anzai K, Tsuruya K, Ida K, Kagawa T, Inagaki Y, Kamiya A. Kruppel-like factor 15 induces the development of mature hepatocyte-like cells from hepatoblasts. Sci Rep. 2021;11:18551.","journal-title":"Sci Rep"},{"key":"1651_CR9","doi-asserted-by":"publisher","first-page":"14254","DOI":"10.1096\/fj.201901347RR","volume":"33","author":"L Zhou","year":"2019","unstructured":"Zhou L, Li Q, Chen A, Liu N, Chen N, Chen X, et al. KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction via NF-kappaB-FGF21 or SREBP1c-FGF21 pathway. FASEB J. 2019;33:14254\u201369.","journal-title":"FASEB J"},{"key":"1651_CR10","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1021\/acs.chemrestox.0c00192","volume":"33","author":"G Wang","year":"2020","unstructured":"Wang G, Wu B, Cui Y, Zhang B, Jiang C, Wang H. Teneligliptin promotes bile acid synthesis and attenuates lipid accumulation in obese mice by targeting the KLF15-Fgf15 pathway. Chem Res Toxicol. 2020;33:2164\u201371.","journal-title":"Chem Res Toxicol"},{"key":"1651_CR11","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/dmd.123.001617","volume":"52","author":"W Hou","year":"2024","unstructured":"Hou W, Huo KG, Guo X, Xu M, Yang Y, Shi Z, et al. KLF15-Cyp3a11 axis regulates rifampicin-induced liver injury. Drug Metab Dispos. 2024;52:606\u201313.","journal-title":"Drug Metab Dispos"},{"key":"1651_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nprot.2013.032","volume":"8","author":"A Bertola","year":"2013","unstructured":"Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc. 2013;8:627\u201337.","journal-title":"Nat Protoc"},{"key":"1651_CR13","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2020.04.038","volume":"73","author":"Q Song","year":"2020","unstructured":"Song Q, Chen Y, Wang J, Hao L, Huang C, Griffiths A, et al. ER stress-induced upregulation of NNMT contributes to alcohol-related fatty liver development. J Hepatol. 2020;73:783\u201393.","journal-title":"J Hepatol"},{"key":"1651_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41401-023-01171-x","volume":"45","author":"LJ Sun","year":"2024","unstructured":"Sun LJ, Chen X, Zhu S, Xu JJ, Li XF, Diao SX, et al. Hesperetin derivative 2a inhibits lipopolysaccharide-induced acute liver injury in mice via downregulation of circDcbld2. Acta Pharmacol Sin. 2024;45:354\u201365.","journal-title":"Acta Pharmacol Sin"},{"key":"1651_CR15","doi-asserted-by":"publisher","first-page":"e77851","DOI":"10.1371\/journal.pone.0077851","volume":"8","author":"DY Jung","year":"2013","unstructured":"Jung DY, Chalasani U, Pan N, Friedline RH, Prosdocimo DA, Nam M, et al. KLF15 is a molecular link between endoplasmic reticulum stress and insulin resistance. PLoS One. 2013;8:e77851.","journal-title":"PLoS One"},{"key":"1651_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ki.2010.539","volume":"79","author":"X Gao","year":"2011","unstructured":"Gao X, Huang L, Grosjean F, Esposito V, Wu J, Fu L, et al. Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5\/6 nephrectomized rats: a role for KLF15. Kidney Int. 2011;79:987\u201396.","journal-title":"Kidney Int"},{"key":"1651_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03932-y","volume":"21","author":"K Yang","year":"2023","unstructured":"Yang K, Qiu T, Zhou J, Gong X, Zhang X, Lan Y, et al. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma. J Transl Med. 2023;21:85.","journal-title":"J Transl Med"},{"key":"1651_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0435-y","volume":"9","author":"WK Shi","year":"2018","unstructured":"Shi WK, Zhu XD, Wang CH, Zhang YY, Cai H, Li XL, et al. PFKFB3 blockade inhibits hepatocellular carcinoma growth by impairing DNA repair through AKT. Cell Death Dis. 2018;9:428.","journal-title":"Cell Death Dis"},{"key":"1651_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jcmgh.2022.09.009","volume":"15","author":"Q Dou","year":"2023","unstructured":"Dou Q, Grant AK, Callahan C, Coutinho de Souza P, Mwin D, Booth AL, et al. PFKFB3-mediated pro-glycolytic shift in hepatocellular carcinoma proliferation. Cell Mol Gastroenterol Hepatol. 2023;15:61\u201375.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1651_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.gastro.2020.03.008","volume":"159","author":"M Mejias","year":"2020","unstructured":"Mejias M, Gallego J, Naranjo-Suarez S, Ramirez M, Pell N, Manzano A, et al. CPEB4 increases expression of PFKFB3 to induce glycolysis and activate mouse and human hepatic stellate cells, promoting liver fibrosis. Gastroenterology. 2020;159:273\u201388.","journal-title":"Gastroenterology"},{"key":"1651_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12986-021-00628-2","volume":"18","author":"C Wang","year":"2021","unstructured":"Wang C, Chu X, Deng Y, Wang J, Qiu T, Zhu J, et al. PA and OA induce abnormal glucose metabolism by inhibiting KLF15 in adipocytes. Nutr Metab. 2021;18:100.","journal-title":"Nutr Metab"},{"key":"1651_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/febs.16957","volume":"291","author":"Y Takeuchi","year":"2024","unstructured":"Takeuchi Y, Murayama Y, Aita Y, Mehrazad Saber Z, Karkoutly S, Tao D, et al. GR-KLF15 pathway controls hepatic lipogenesis during fasting. FEBS J. 2024;291:259\u201371.","journal-title":"FEBS J"},{"key":"1651_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.phrs.2017.12.018","volume":"130","author":"L Fan","year":"2018","unstructured":"Fan L, Hsieh PN, Sweet DR, Jain MK. Kruppel-like factor 15: regulator of BCAA metabolism and circadian protein rhythmicity. Pharmacol Res. 2018;130:123\u20136.","journal-title":"Pharmacol Res"},{"key":"1651_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135371","volume":"279","author":"X Zhang","year":"2024","unstructured":"Zhang X, Tian X, Wang Y, Yan Y, Wang Y, Su M, et al. Application of lipopolysaccharide in establishing inflammatory models. Int J Biol Macromol. 2024;279:135371.","journal-title":"Int J Biol Macromol"},{"key":"1651_CR25","doi-asserted-by":"publisher","first-page":"201625","DOI":"10.1155\/2015\/201625","volume":"2015","author":"DA Prosdocimo","year":"2015","unstructured":"Prosdocimo DA, John JE, Zhang L, Efraim ES, Zhang R, Liao X, et al. KLF15 and PPARalpha cooperate to regulate cardiomyocyte lipid gene expression and oxidation. PPAR Res. 2015;2015:201625.","journal-title":"PPAR Res"},{"key":"1651_CR26","doi-asserted-by":"publisher","first-page":"e2200173","DOI":"10.1002\/mnfr.202200173","volume":"66","author":"Y Hu","year":"2022","unstructured":"Hu Y, Xu J, Gao R, Xu Y, Huangfu B, Asakiya C, et al. Diallyl trisulfide prevents adipogenesis and lipogenesis by regulating the transcriptional activation function of KLF15 on PPARgamma to ameliorate obesity. Mol Nutr Food Res. 2022;66:e2200173.","journal-title":"Mol Nutr Food Res"},{"key":"1651_CR27","doi-asserted-by":"publisher","first-page":"176113","DOI":"10.1016\/j.ejphar.2023.176113","volume":"960","author":"J Xiao","year":"2023","unstructured":"Xiao J, Xiang H, Xiang H, Sun Z, Xu J, Ren H, et al. GW9662 ameliorates nonalcoholic steatohepatitis by inhibiting the PPARgamma\/CD36 pathway and altering the gut microbiota. Eur J Pharmocol. 2023;960:176113.","journal-title":"Eur J Pharmocol"},{"key":"1651_CR28","doi-asserted-by":"publisher","first-page":"e2200742","DOI":"10.1002\/advs.202200742","volume":"9","author":"H Lin","year":"2022","unstructured":"Lin H, Wang L, Liu Z, Long K, Kong M, Ye D, et al. Hepatic MDM2 causes metabolic associated fatty liver disease by blocking triglyceride-VLDL secretion via ApoB degradation. Adv Sci. 2022;9:e2200742.","journal-title":"Adv Sci"},{"key":"1651_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","volume":"414","author":"AR Saltiel","year":"2001","unstructured":"Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414:799\u2013806.","journal-title":"Nature"},{"key":"1651_CR30","doi-asserted-by":"publisher","first-page":"22424","DOI":"10.1002\/jcp.28807","volume":"234","author":"HH Arab","year":"2019","unstructured":"Arab HH, Salama SA, Eid AH, Kabel AM, Shahin NN. Targeting MAPKs, NF-kappaB, and PI3K\/AKT pathways by methyl palmitate ameliorates ethanol-induced gastric mucosal injury in rats. J Cell Physiol. 2019;234:22424\u201338.","journal-title":"J Cell Physiol"},{"key":"1651_CR31","first-page":"1029","volume":"119","author":"S Han","year":"2009","unstructured":"Han S, Liang CP, Westerterp M, Senokuchi T, Welch CL, Wang Q, et al. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. J Clin Invest. 2009;119:1029\u201341.","journal-title":"J Clin Invest"},{"key":"1651_CR32","doi-asserted-by":"publisher","first-page":"115246","DOI":"10.1016\/j.celrep.2025.115246","volume":"44","author":"L Song","year":"2025","unstructured":"Song L, Huang Y, Liu L, Chang X, Hu L, Wang G, et al. Meteorin-like alleviates hepatic steatosis by regulating hepatic triglyceride secretion and fatty acid oxidation. Cell Rep. 2025;44:115246.","journal-title":"Cell Rep"},{"key":"1651_CR33","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3389\/fphar.2018.01031","volume":"9","author":"YY Sun","year":"2018","unstructured":"Sun YY, Zhao YX, Li XF, Huang C, Meng XM, Li J. beta-Arrestin 2 promotes hepatocyte apoptosis by inhibiting Akt pathway in alcoholic liver disease. Front Pharmacol. 2018;9:1031.","journal-title":"Front Pharmacol"},{"key":"1651_CR34","doi-asserted-by":"publisher","first-page":"102485","DOI":"10.1016\/j.tice.2024.102485","volume":"90","author":"H Zheng","year":"2024","unstructured":"Zheng H, Ye W, Huang K, Chen Q, Yang J, Luo L. KLF15 alleviates oxidative stress and apoptosis of H\/R-induced trophoblast cells to improve invasion and migration capacity via the activation of IGF1R. Tissue Cell. 2024;90:102485.","journal-title":"Tissue Cell"},{"key":"1651_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","volume":"14","author":"JL Yecies","year":"2011","unstructured":"Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 2011;14:21\u201332.","journal-title":"Cell Metab"},{"key":"1651_CR36","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1002\/hep.23175","volume":"50","author":"N Bijl","year":"2009","unstructured":"Bijl N, Sokolovic M, Vrins C, Langeveld M, Moerland PD, Ottenhoff R, et al. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. Hepatology. 2009;50:1431\u201341.","journal-title":"Hepatology"},{"key":"1651_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yjmcc.2023.11.006","volume":"186","author":"ZK Song","year":"2024","unstructured":"Song ZK, Zhao L, Liu DS, Zhao LN, Peng QB, Li ZY, et al. Macrophage KLF15 prevents foam cell formation and atherosclerosis via transcriptional suppression of OLR-1. J Mol Cell Cardiol. 2024;186:57\u201370.","journal-title":"J Mol Cell Cardiol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01651-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T14:06:51Z","timestamp":1768572411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01651-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01651-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}